{
    "nctId": "NCT05298072",
    "briefTitle": "Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer Patients",
    "officialTitle": "Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer Patients",
    "overallStatus": "UNKNOWN",
    "conditions": "Cardiotoxicity, Breast Cancer, Heart Failure",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 180,
    "primaryOutcomeMeasure": "Cardiotoxicity during observational period",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* initial diagnosis of breast cancer\n* planned Anthracycline-based therapy\n* first-line chemotherapy\n* first visit before initiation of chemotherapy\n\nExclusion Criteria:\n\n* previous chemotherapy\n* medical history of cardiac disease\n* inflammation-modulating medication\n* medication with RAS inhibitors\n* pregnancy\n* autoimmune disease\n* drug addictions\n* unwilling or unable to provide informed consent",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}